In Other News

• Sputum-Based Lung Cancer Test Technology Granted Hong Kong Patent

• Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

• Multimodal AI Improves Treatment Response Prediction in Lung Cancer

• Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

• Machine Learning Cytology Tool Improves Cancer Cell Identification

• Updated Ferritin Thresholds Improve Detection of Iron Deficiency

• Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

• FDA Clears Compact Molecular COVID Test for Decentralized Care Settings

• Genetic Studies Uncover Mechanisms Driving Drug Resistance in Klebsiella pneumoniae

• Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

• New Automated Hemostasis Systems Become Available Across US Laboratories

• ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

• Tumor Budding Grading May Predict Chemotherapy Benefit in Resected Lung Squamous Cancer

• Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework

• Variation in AML Residual Disease Testing Prompts Push for Standardization

• CAP Updates Cancer Protocols to Refine Breast Cancer Biomarker Reporting and GIST Molecular Testing

• New Automated Hemostasis Systems Become Available Across US Laboratories

• ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

• CAP Updates Cancer Protocols to Refine Breast Cancer Biomarker Reporting and GIST Molecular Testing

• Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

• Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

• Machine Learning Supports Targeted Screening for Elevated Lipoprotein(a)

• Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities